Ethris

Paving a new path from genes to therapeutic proteins

Munich, Germany · Founded 2009 · $69.3M raised

Headquarters
Munich
Employees
11–50
Founded
2009
Business Model
B2B
Website
ethris.com
Total Funding
$69.3M
Last Round
$15.0M GrantJan 2025
Rounds
4

About

Ethris GmbH is a clinical-stage biotechnology company based in Planegg near Munich, Germany, pioneering next-generation messenger RNA (mRNA) therapeutics and vaccines for severe respiratory diseases. Founded by Dr. Carsten Rudolph and Prof. Dr. Christian Plank, Ethris developed its proprietary SNIM® RNA and SNaP LNP® delivery platforms, which enable multi-route administration of mRNA including differentiated inhaled delivery directly to the lungs—a key differentiator for treating conditions such as asthma and COPD. The company has entered strategic collaborations with major partners including AstraZeneca and MedImmune to advance its mRNA programs, and its lead asset ETH47 targets the prevention of asthma exacerbations.

Summary

Ethris is a Biotech company based in Munich, Germany, founded in 2009. It has raised $69.3M in total across 4 rounds, most recently a $15.0M Grant round in Jan 2025. Investors include Cipla, Laureus Capital and OrbiMed.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2025

Sign up to see all 4 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ethris on Indexed.vc
<a href="https://indexed.vc/companies/ethris"><img src="https://indexed.vc/api/badge/company/ethris" alt="Ethris on Indexed.vc" width="260" height="76" /></a>